Nanotech lets doctors camera see cancer cells
28 June, 2010 by Sharon GaudinResearchers have added nanoechnology to an off-the-shelf digital camera to help doctors distinguish healthy cells from cancerous cells in the human body.
Revolutionary new Alzheimer’s test awaits FDA approval
25 June, 2010 by David BinningA U.S company is nearing approval for a new scanning and dye procedure which could revolutionise the diagnosis and treatment of Alzheimer’s.
Major new African gene study announced
24 June, 2010 by David BinningAn ambitious new health project announced this week will seek to capitalise on Africa’s unique genetic diversity in a bid to further understanding of how genes interact with the environment in relation to diseases such as cancer, heart disease and malaria.
Melanoma cases to double over next decade
23 June, 2010 by David BinningThe number of melanoma cases will double over the next 10 years, presenting attractive opportunities for drug companies to improve on existing poor and outdated standards of treatment.
Melanoma cases to double over next decade
23 June, 2010 by David BinningThe number of cases of melanoma will double over the next 10 years, presenting attractive opportunities for drug companies to improve on existing poor and outdated standards of treatment.
Swine flu follow-up criticised as inadequate
22 June, 2010 by Staff WritersA study by Hong Kong researchers has highlighted worrying gaps in the follow up to last year’s outbreak of H1N1 swine flu which it says are largely responsible for a fast-spreading outbreak amongst pigs in China.
Study reveals link between tea and rheumatoid arthritis
18 June, 2010 by Staff WritersA new study has shown that even mild levels of tea drinking can greatly increase the chances of developing rheumatoid arthritis while coffee appears to have no effect at all.
UK scientists discover new genetic indicators for testicular cancer
18 June, 2010 by Staff WritersResearchers at the UK’s Institute of Cancer Research (ICR) have highlighted three new genetic risk factors for testicular cancer, doubling the number of genomic regions now known to be associated with the disease.
New Australian cancer drug advances towards human trials
14 June, 2010 by Staff WritersQueensland biotech QBiotics announced at the weekend it is seeking to raise $10 million to fund Phase 1 human trials of its EBC-46 cancer drug.
Monash PhD student leads major insulin breakthrough
11 June, 2010 by David BinningA PhD student from Monash University has succeeded in tweaking the chemical structure of insulin leading potentially to the development of medications that are stable at room temperature.
Gene mutation confirmed as a key to treating melanoma
11 June, 2010 by Staff WritersDoubts about the role played by mutations in the gene BRAF in the development of melanoma have largely been laid to rest by new research which confirms that drugs inhibiting the gene greatly increase chances of survival.
Dynamin linked to Alzheimer's and bipolar disorder
08 June, 2010 by Tim DeanDynamin is well known for its role in controlling endocytosis, particularly in synaptic vesicles in nerve cells and for its pivotal role in the brain.
UQ brain researcher honoured
08 June, 2010 by Staff WritersUniversity of Queensland Associate professor Nancy Pachana has been awarded the 2010 ADC ( Australian Davos Connection ) Future Summit Leadership Award for her contribution to medical understanding of how the brain ages.
Feature: Diagnostics and living to 100
04 June, 2010 by Graeme O'NeillA scraping of buccal cells from the lining of the cheek can predict, with a high measure of reliability, one’s risk of developing Alzheimer’s disease, or determine how far they have already progressed towards dementia. From the ability to predict, comes the prospect of being able to prevent.
Heparin study could mark malaria breakthrough
03 June, 2010 by Staff WritersResearchers from Australia’s Walter and Eliza Hall and Burnett Institutes, and the Imperial College London have completed a potentially ground breaking study examining the ability of heparin-like molecules to neutralise the malaria virus before it reaches the red blood cells.
